Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 2, 1996, Pages 133-138

  Arinami, Tadao ^a   Itokawa, Masanari ^b   Aoki, Junichi ^b   Shibuya, Haruo ^b   Ookubo, Yoshiro ^b   Iwawaki, Atsushi ^b   Ota, Katsuya ^b   Shimizu, Hiromitsu ^c   Hamaguchi, Hideo ^a   Toru, Michio ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Hokushin General Hospital   (Japan)

Author keywords

Candidate gene; Psychiatric disorders; S311C

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CONTROLLED STUDY; DELUSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FAMILIAL DISEASE; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; VARIATION (GENETICS);

EID: 0029965226     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960409)67:2<133::AID-AJMG2>3.0.CO;2-T     Document Type: Article

References (48)

1. Andreasen NC, Flaum M, Arndt S, Alliger R, Swayze VW (1991): Positive and negative symptoms: Assessment and validity. In Marneros A, Andreasen NC, Tsuang MT (eds): "Negative Versus Positive Schizophrenia." Berlin: Springer-Verlag, pp 28-51.
2. Andreasen NC, Olsen S (1982): Negative vs positive schizophrenia. Arch Gen Psychiatry 39.789-794.
3. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, Hamaguchi H, Toni M (1994): Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703-704.
4. Ashcrson P, Williams N, Roberts E, McGuffin M, Owen M (1994): DRD2 Der311/Cys311 polymorphism in schizophrenia Lancet 343:1045.
5. Bassett AS, Collins EJ, Nuttall SE, Honer WG (1993): Positive and negative symptoms in families with schizophrenia. Schizophr Res 11:9-19.
6. Carpenter WT, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F (1993): Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry 50:825-831.
7. Cloninger CR (1994): Turning point in the design of linkage studies of schizophrenia. Am J Med Genet 54:83-92.
8. Coon H, Byerley W, Holik J, Hoff M, Myles-Worsley M. Lannfelt L, Sokoloff P, Schwartz J-C, Waldo M, Freedman R, Plaetke R (1993): Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am J Hum Genet 52:327-334.
9. Coon H, Jensen S, Holik J, Hoff M, Myles-Sorsley M, Reimherr F, Wender P, Waldo M, Freedman R, Leppert M, Byerley W (1994): Genomic scan for genes predisposing to schizophrenia Am J Med Genet 54:59-71.
10. Crocq M-A, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier D, Lannfelt L, Sokoloff P, Schwartz J-C, Gill M, Macher J-P, McGuffin P, Owen MJ (1992): Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29:858-860.
11. Crow TJ (1980): Molecular pathology of schizophrenia: More than one disease process? Br Med J 280:66-68.
12. Daniels J, Williams J, Mant R, Asherson P, McGuffin P, Owen MJ (1994): Repeat length variation in the dopamine D4 receptor gene shows no evidence of association with schizophrenia. Am J Med Genet 54.256-258.
13. Di Bella D, Catalano M, Strukel A, Nobile M, Novelli E, Smeraldi E (1994): Distribution of the MscI polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatr Genet 4: 39-42.
14. Dworkin RH, Lenzenweger MF, Moldin SO, Skillings GF, Levick SE (1988): A multidimensional approach to the genetics of schizophrenia. Am J Psychiatry 145:1077-1083.
15. Farmer AE, McGuffin P, Gottesman II (1987): Twin concordance for DSM-III schizophrenia. Arch Gen Psychiatry 44:634-641.
16. Friedman E, Adams EF, Hoog A, Gejman PV, Carson E, Larsson C, De Marco L, Werner S, Fahlbusch R, Nordenskjbld M (1994): Normal structural dopamine type 2 receptor gene in prolactin-seereting and other pituitary tumors. J Clin Endocrinol Metab 78:568-574.
17. 2 receptor gene in alcoholism or schizophrenia. JAMA 271:204-208.
18. Gottesman II, Shields J (1982): "Schizophrenia, the Epigenetic Puzzle." Cambridge: Cambridge University Press
19. Gottesman II (1994). Complications to the complex inheritance of schizophrenia. Clin Genet 46:116-123.
20. Häfner H, Maurer K (1991): Are there two types of schizophrenia? True onset and sequence of positive and negative syndromes prior to first admission. In Marneros A, Andreasen NC, Tsuang MT (eds): "Negative Versus Positive Schizophrenia." Berlin: Springer-Verlag, pp 134-159
21. Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M (1993): A structural polymorphism of human dopamine D2 receptor, D2(Ser311→Cys). Biochem Biophys Res Commun 196:1369-1375.
22. 3 receptor gene Acta Psychiatr Scand 87:345-349.
23. Kendler KS (1991): Mood-incongruent psychotic affective illness Arch Gen Psychiatry 48.362-369.
24. Kendler KS, Gruenberg AM, Tsuang MT (1986): A DSM-III family study of the nonschizophrenic psychotic disorders. Am J Psychiatry 143:1098-1105.
25. Krawiecka MD, Goldberg D, Vaughan M (1977): A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 55:299-308.
26. 3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2:249-256.
27. Laurent C, Bodeau-Péan S, Campion D, d'Amato T, Jay M, Dollfus S, Thibault F, Petit M, Samolyk D, Martinez M, Mallet J (1994): No major role for the dopamine D2 receptor Ser→Cys311 mutation in schizophrenia. Psychiatr Genet 4:229-230.
28. Macciardi F, Verga M, Kennedy JL, Petronis A, Bersani G, Pancheri P, Smeraldi E (1994): An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk. Hum Hered 44:328-336.
29. 3 receptors Mol Pharmocol 43:749-754.
30. Mant R, Williams J, Asherson P, Parfitt E, McGuffin P, Owen MJ (1994): Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet 54:21-26.
31. Maurer K, Hàfner H (1991): Dependence, independence or interdependence of positive and negative symptoms. In Marneros A, Andreasen NC, Tsuang MT (eds): "Negative Versus Positive Schizophrenia." Berlin. Springer-Verlag, pp 160-182.
32. Moises HW, Gelernter J, Giuffra LA, Zarcone V, Wetterberg L, Civelli O, Kidd KK, Cavalli-Sforza LL (1991). No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry 48:643-647.
33. Nanko S, Hattori M, Dai XY, Fukuda R, Kazamatsuri H (1994): DRD2 Der311/Cys311 polymorphism in schizophrenia. Lancet 343:1044.
34. 3 receptor gene. Hum Genet 92: 336-338.
35. Nimgaonkar VL, Zhang XR, Caldwell JG, Ganguli R, Chakravarti A (1993): Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: Probable effects of family history of schizophrenia? Am J Med Genet 48:214-217.
36. Nothen MM, Cihon S, Propping P, Fimmers R, Schwab SG, Sildernauer DB (1993a). Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed. J Med Genet 30:708.
37. 1 receptor loci. Psychiatr Genet 3: 89-94.
38. Nothen MM. Wildenauer D, Cichon S, Albus M, Maier W, Minges J, Lichtermann D, Bondy B, Riestschel M, Körner J, Fimmers R, Propping P (1994): Dopamine D2 receptor molecular variant and schizophrenia. Lancet 343:301-1302.
39. Saha N, Tsoi WF, Low PS, Basair J, Tay JSH (1994): Lack of association of the dopamine D3 receptor gene polymorphism (Ball) in Chinese schizophrenic males. Psychiatr Genet 4:201-204.
40. Sarkar G, Kapelner S, Grandy DK, Marchionni M, Civelli O, Sobell J, Heston L, Sommer SS (1991): Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11: 8-14.
41. Shaikh S, Collier D, Arranz M, Ball D, Gill M, Kerwin R (1994): DRD2 Der311/Cys311 polymorphism in schizophrenia. Lancet 343:1045-1046.
42. Shaikh S, Collier D, Kerwin RW, Pilowsky LS, Gill M, Xu W-M, Thornton A (1993): Dopamine D4 receptor subtypes and response to clozapine. Lancet 341-116.
43. Sobell J, Sigurdson DC, Heston L, Sommer S (1994): S311C D2DR variant: No association with schizophrenia. Lancet 344:621-622.
44. Sommer SS, Lind TJ, Heston LL, Sobell JL (1993): Dopamine D4 receptor variants in unrelated schizophrenic cases and controls Am J Med Genet 48.90-93.
45. Strauss JS, Carpenter WT, Bartko JJ (1974): The diagnosis and understanding of schizophrenia, part III: Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1:61-69.
46. Su Y, Burke J, O'Neill FA, Murphy B, Nie L, Kipps B, Bray J, Shinkwm R, Nuallain MN, MacLean CJ, Walsh D, Diehl SR, Kendler KS (1993): Exclusion of linkage between schizophrenia and the D2 dopamine receptor gene region of chromosome 11q in 112 Irish multiplex families. Arch Gen Psychiatry 50:205-211.
47. Toru M, Watanabe S, Shibuya H, Nishikawa T, Noda K, Mitsushio H, Ichikawa H, Kurumaji A, Takashima M, Mataga N, Ogawa A (1988): Neurotransmitters, receptors and neuropeptides in postmortem brains of chronic schizophrenic patients Acta Psychiatr Scand 78:121-137.
48. Yang L, Li T, Wiese C, Lannfelt L, Sokoloff P, Xu CT, Zeng Z, Schwartz J-C, Liu X, Moises HW (1993): No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am J Med Genet 48:83-86.